These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 6237529)
1. [Comparative evaluation of the effectiveness of 2 methods of immunoglobulin prophylaxis of hepatitis A in areas with high morbidity in this infection]. Gorbunov MA; Sumarokov AA; Iaroshevskaia IIu; Ikoev VN; Kudriakova RA Zh Mikrobiol Epidemiol Immunobiol; 1984 Aug; (8):101-4. PubMed ID: 6237529 [TBL] [Abstract][Full Text] [Related]
2. [Effect of immunoglobulin prophylaxis on the incidence of the development of anicteric forms of hepatitis A]. Gorbunov MA; Sumarokov AA; Ikoev VN; Iaroshevskaia IIu; Kudriakova RA Zh Mikrobiol Epidemiol Immunobiol; 1985 Oct; (10):57-60. PubMed ID: 2936044 [TBL] [Abstract][Full Text] [Related]
3. [A trial of using immunoglobulins of known specificity for preventing hepatitis A in regions with high epidemic activity]. Schastnyĭ EI; Iagodovskiĭ VV; Doroshenko NV; Kudasheva LV; Tadzhiev VB; Abdullaeva FA; Bukhal NV; Muminov KhM; Salakhutdinov MS; Ishutina KF Zh Mikrobiol Epidemiol Immunobiol; 1990 May; (5):56-61. PubMed ID: 2143617 [TBL] [Abstract][Full Text] [Related]
5. [Evaluation of the effectiveness of a specific immunoglobulin against hepatitis A]. Slepushkin AN; Gorbunov MA; Stepanchuk VA; Ikoev VN; Opanasiuk LG Zh Mikrobiol Epidemiol Immunobiol; 1987 Apr; (4):52-5. PubMed ID: 2440203 [TBL] [Abstract][Full Text] [Related]
6. [Effect of the content of hepatitis A antibodies in immunoglobulin preparations on the effectiveness of the immunoglobulin prophylaxis of hepatitis A]. Gorbunov MA; Sumarokov AA; Iaroshevskaia IIu; Ikoev VN; Khalitova KA Zh Mikrobiol Epidemiol Immunobiol; 1984 Jun; (6):86-9. PubMed ID: 6087581 [TBL] [Abstract][Full Text] [Related]
7. [The evaluation of the late effect of the multiple administration of immunoglobulin on hepatitis A morbidity in organized collectives]. Katkov AI; Semenenko TA; Vasil'eva VI Voen Med Zh; 1991 Nov; (11):35-7. PubMed ID: 1668550 [TBL] [Abstract][Full Text] [Related]
8. [Efficiency of normal human immunoglobulins in the prevention of infectious hepatitis]. Spînu I; Zavate O; Constantinesco N; Manta I; Avram G; Buzdugan I; Vîrnă G; Ghibu F; Dumitriu G Arch Roum Pathol Exp Microbiol; 1968 Dec; 27(4):883-92. PubMed ID: 4193082 [No Abstract] [Full Text] [Related]
9. [Experience with the use of immunoglobulin prophylaxis of hepatitis A in the lithuanian SSR. The prophylactic action of different doses of a commercial immunoglobulin depending on the epidemic situation]. Iurkuvenas VB; Zak MR; Sangaĭla IV; Gurchinas SV; Tarbunas SI Vopr Virusol; 1982; 27(2):243-7. PubMed ID: 7090352 [No Abstract] [Full Text] [Related]
10. [Experience with the use of immunoglobulin prophylaxis of hepatitis A in the Lithuanian SSR. The prophylactic action of different doses of a commercial immunoglobulin in a pre-epidemic period]. Iurkuvenas VB; Zak MR; Sangaĭla IV; Gurchinas SV; Tarbunas SI Vopr Virusol; 1982; 27(2):241-3. PubMed ID: 7090351 [No Abstract] [Full Text] [Related]
11. [An analysis of the seasonal rise in hepatitis A morbidity at a children's center and ways to improve the sanitary epidemiologic surveillance for this infection among organized preschoolers]. Gudkov VG; Rytik PG; Tomal' LS; Sket VA; Chernovetskiĭ MA; Antipova SI; Kulichkovskaia IV; Drusviatskaia BM Zh Mikrobiol Epidemiol Immunobiol; 1990 Mar; (3):39-44. PubMed ID: 2164289 [TBL] [Abstract][Full Text] [Related]
12. [Effectiveness of preseason serum prevention of hepatitis A using different doses of 10% commercial immunoglobulin]. Gorbunov MA; Sumarokov AA; Zak MR; Iurkuvenas VB; Lelikov VL Zh Mikrobiol Epidemiol Immunobiol; 1981 Jul; (7):103-10. PubMed ID: 6456633 [No Abstract] [Full Text] [Related]
13. [Epidemiological analysis of hepatitis A morbidity]. Suslov IM; Tkachenko GM; Kalenchuk AA; Astakhov AS Zh Mikrobiol Epidemiol Immunobiol; 1988 Jun; (6):39-43. PubMed ID: 3176780 [TBL] [Abstract][Full Text] [Related]
14. [Analysis of gamma globulin prophylaxis in foci of infectious hepatitis]. Masár I; Puceková G; Stukovský L Cesk Epidemiol Mikrobiol Imunol; 1969 Oct; 18(5):325-36. PubMed ID: 4188573 [No Abstract] [Full Text] [Related]
15. [Epidemiologic characteristics of hepatitis A morbidity among children from one of the districts of Moscow in 1982-1986]. Fedorova GI; Slepushkin AN; Doroshenko NV; Panina GM; Iagodovskiĭ VV Vopr Virusol; 1988; 33(6):686-90. PubMed ID: 3247687 [TBL] [Abstract][Full Text] [Related]
16. [Epidemiology of viral hepatitis in the Estonian SSR]. Reĭnaru IK; Belokon VN; Mirochnik VV; Miartin IaK; Jogiste AK Zh Mikrobiol Epidemiol Immunobiol; 1980 Aug; (8):94-100. PubMed ID: 6160704 [TBL] [Abstract][Full Text] [Related]
17. The protective efficacy of immune serum globulin in hepatitis A: a statistical approach. Landrigan PJ; Huber DH; Murphy GD; Creech WB; Bryan JA JAMA; 1973 Jan; 223(1):74-5. PubMed ID: 4739093 [No Abstract] [Full Text] [Related]
18. [Scientific and applied aspects of the control of viral hepatitis]. Sumarokov AA; Balaian MS; Gorbunov MA; Narkevich MI Zh Mikrobiol Epidemiol Immunobiol; 1984 Jul; (7):16-21. PubMed ID: 6435354 [TBL] [Abstract][Full Text] [Related]
19. [Epidemiological characteristics of viral hepatitis in the Mongolian People's Republic]. Zhamba G; Gorbunov MA; Shakhgil'dian IV; Trofimova LI; Damdinsurén A Zh Mikrobiol Epidemiol Immunobiol; 1983 Jan; (1):86-9. PubMed ID: 6837198 [TBL] [Abstract][Full Text] [Related]